Natera, Inc. (NTRA) stock
Close on Nov 12, 2026Market cap $46.55BP/E –Yield –
Natera, Inc. grew revenue 37.4% to $2.91B over the twelve months to Sep 30, 2026. Free cash flow was $52.47M, down 50.5% from a year earlier. At the latest close the market valued the company at $46.55B.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $46.55B
- P/E ratio
- –
- Price to sales
- 16.00
- Price to book
- 24.90
- Dividend yield
- –
- Free cash flow yield
- 0.11%
Fundamentals
- Revenue
- $2.91B
- Net income
- -$164.71M
- EPS, diluted
- -$1.15
- Free cash flow
- $52.47M
- Book value per share
- $12.98
- Diluted shares
- 144M
Trading
- Next earnings
- Feb 25, 2027 (estimated, after the close)
- Previous close
- $319.82
- Open
- $310.99
- Day's range
- $304.65 – $326.92
- Volume
- 1,500,784
- Average volume (20 days)
- 2,122,397
- Index membership
- Russell 1000 (since Jun 2021), Russell 3000
- Beta (5 years)
- 1.39
- 52-week range
- $181.00 – $437.41
- RSI (14 days)
- 34.9
- Volatility (1 year)
- 52.2%
- Relative volume
- 0.95×
- WACC
- 11.8%
On 1 of our idea list: Superinvestor favorites
Index membership is inferred from the holdings of funds that track each index (IWB, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2015, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | NTRA | S&P 500 | Difference | NTRA per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -18.8% | -2.7% | −16.1 pts | ||
| 3 months | +2.2% | -1.7% | +4.0 pts | ||
| Year to date | +41.0% | +11.9% | +29.1 pts | ||
| 1 year | +54.1% | +12.0% | +42.2 pts | ||
| 3 years | +590.9% | +78.2% | +512.8 pts | +90.5% | +21.2% |
| 5 years | +180.7% | +73.2% | +107.5 pts | +22.9% | +11.6% |
| 10 years | +2796.3% | +309.6% | +2486.7 pts | +40.0% | +15.1% |
Fourteen years at a glance
Fiscal years 2012 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Natera filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
About Natera
Services-Medical Laboratories
The company is a diagnostics provider specializing in cell-free DNA molecular assays and bioinformatics algorithms across oncology, women's health, and organ health. In oncology, it offers tests for molecular residual disease detection, recurrence monitoring, and therapy selection, serving oncology clinics, cancer researchers, and biopharmaceutical partners. In women's health, its portfolio includes non-invasive prenatal screening, carrier screening, and pregnancy loss evaluation. In organ health, it supplies tests to detect transplant rejection in heart, lung, and kidney recipients, as well as genetic panels for chronic kidney disease. It also licenses its cloud bioinformatics platform to external clinical laboratories.
Company profile, executives and historyNatera stock: common questions
What is Natera's stock price?
NTRA closed at $322.94 on Nov 12, 2026, up 0.98% on the day. Over the past 52 weeks it traded between $181.00 and $437.41.
What is Natera's market cap?
Natera was worth $46.55B at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is NTRA's P/E ratio?
Natera lost money over the twelve months to Sep 30, 2026 (diluted EPS -$1.15), so it has no meaningful P/E ratio.
How much revenue does Natera make?
Natera reported revenue of $2.91B for the twelve months to Sep 30, 2026, up 37.4% from a year earlier.
Does Natera pay a dividend?
No. Natera has not paid a cash dividend over the last twelve months.
When does Natera report earnings next?
Natera is expected to report Q4 FY2026 results on Feb 25, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has NTRA stock performed over the past year?
Including dividends, NTRA returned +54.1% over the past year, against +12.0% for the S&P 500.
How many NTRA shares are sold short?
6M shares were sold short at the latest FINRA report, 4.39% of the float, or 4.2 days of average trading volume.
Who are Natera's competitors?
Companies most similar to Natera by business, industry and size include GH, FTRE, CAI, VCYT, BLLN.
See a number that looks wrong?